Charles River Laboratories CRL Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies

TFS FinancialTFSL

863.8K+1,645%

Baxter InternationalBAX

4.1M+295%

RBC BearingsRBC

124-81.6%

Coeur MiningCDE

43.3K+203%

Charles River LaboratoriesCRL

40K—

Jazz PharmaceuticalsJAZZ

340K-36.6%

Other financials

Income statement

See full

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

See full

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

See full

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

See full

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

See full

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

See full

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's share-based compensation arrangement by share-based payment award, options, expirations in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's share-based compensation arrangement by share-based payment award, options, expirations in period?: Charles River Laboratories (CRL) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 40K in Q4 2025.
What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?: The number of stock options that reached the end of their term without being exercised during the reporting period. This reflects the portion of equity incentives that did not result in share issuance.